project id: TCGA-BRCA; case submitter id: TCGA-Z7-A8R6; source center: 23; state: released; a260 a280 ratio: 1.93; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.99; rna integrity number: 8.7; age at index: 46; days to birth: -16955; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1959; age at diagnosis: 16955; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1c; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 3256.0; icd 10 code: C50.8; last known disease status: not reported; morphology: 8022/3; primary diagnosis: Pleomorphic carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Overlapping lesion of breast; synchronous malignancy: No; tissue or organ of origin: Overlapping lesion of breast; tumor grade: Not Reported; year of diagnosis: 2005; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 3020; days to sample procurement: 0; initial weight: 520.0; portion submitter id: TCGA-Z7-A8R6-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 5.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0;